Review
Published on 21 Aug 2024
Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1442673
- 1,362 views
Type at least 3 characters
6,679 articles
Articles
Case Report
Published on 21 Aug 2024
Potential therapeutic option for EGFR-mutant small cell lung cancer transformation: a case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1439033
- 1,689 views
Original Research
Published on 21 Aug 2024
Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1408892
- 2,118 views
Editorial
Published on 21 Aug 2024
Editorial: Women in cancer immunity and immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1466010
- 504 views
Review
Published on 21 Aug 2024
An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1351584
- 1,024 views
- 1 citation
Original Research
Published on 21 Aug 2024
Exploring cell-derived extracellular vesicles in peripheral blood and bone marrow of B-cell acute lymphoblastic leukemia pediatric patients: proof-of-concept study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1421036
- 2,203 views
Review
Published on 20 Aug 2024
Single-cell RNA sequencing in endometrial cancer: exploring the epithelial cells and the microenvironment landscape
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1425212
- 1,900 views
Review
Published on 20 Aug 2024
A role of gut microbiota metabolites in HLA-E and NKG2 blockage immunotherapy against tumors: new insights for clinical application
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1331518
- 1,405 views
Original Research
Published on 20 Aug 2024
Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1397692
- 1,621 views
Review
Published on 20 Aug 2024
The role of RNA modifications in hepatocellular carcinoma: functional mechanism and potential applications
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1439485
- 1,076 views
Original Research
Published on 19 Aug 2024
Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1434450
- 2,083 views
- 1 citation
Retraction
Published on 19 Aug 2024
Retraction: Natural killer cell-derived exosomal miR-3607-3p inhibits pancreatic cancer progression by targeting IL-26
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1480124
- 515 views
Original Research
Published on 19 Aug 2024
GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1396777
- 1,911 views
Retraction
Published on 19 Aug 2024
Retraction: Corrigendum: Natural killer cell-derived exosomal miR-3607-3p inhibits pancreatic cancer progression by targeting IL-26
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1480131
- 391 views
Original Research
Published on 16 Aug 2024
E-cigarette exposure disrupts antitumor immunity and promotes metastasis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1444020
- 1,978 views
Original Research
Published on 16 Aug 2024
Anti-PD-1 combined with hypomethylating agent and CAG regimen bridging to allogeneic hematopoietic stem cell transplantation: a novel strategy for relapsed/refractory acute myeloid leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1409302
- 1,403 views